ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.138,37
0,00%
S&P 500
5.473,23
0,00%
US Dollar vs BRL
5,4228
-0,05%
Bitcoin
64.979,00
-2,27%
Brent Oil
83,915
0,02%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) Notícias

XNCR

Xencor (XNCR)

Xencor Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XNCR
DataHoraFonteTítuloCódigoCompanhia
17/06/202417:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
14/06/202417:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
13/06/202409:01Business WireXencor Regains CD20 x CD3 Bispecific T-Cell EngagerNASDAQ:XNCRXencor Inc
09/05/202417:09Business WireXencor Reports First Quarter 2024 Financial ResultsNASDAQ:XNCRXencor Inc
09/05/202417:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XNCRXencor Inc
09/04/202409:01Business WireXencor Appoints Bart Cornelissen as Chief Financial OfficerNASDAQ:XNCRXencor Inc
11/03/202416:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
28/02/202418:01Business WireXencor to Present at Upcoming Investor ConferencesNASDAQ:XNCRXencor Inc
27/02/202418:01Business WireXencor Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:XNCRXencor Inc
20/02/202418:31Business WireXencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical UpdateNASDAQ:XNCRXencor Inc
16/02/202419:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XNCRXencor Inc
03/01/202418:01Business WireXencor to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XNCRXencor Inc
02/01/202410:01Business WireDane Leone Joins Xencor as Senior Vice President, Corporate StrategyNASDAQ:XNCRXencor Inc
21/11/202318:01Business WireXencor to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:XNCRXencor Inc
07/11/202318:01Business WireXencor Reports Third Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
07/11/202318:01Business WireXencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 MillionNASDAQ:XNCRXencor Inc
03/11/202313:01Business WireXencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual MeetingNASDAQ:XNCRXencor Inc
31/10/202317:01Business WireXencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023NASDAQ:XNCRXencor Inc
26/10/202309:01Business WireXencor Announces Planned Retirement of Chief Financial Officer John KuchNASDAQ:XNCRXencor Inc
27/09/202310:01Business WireXencor to Present Multiple Posters at the SITC Annual MeetingNASDAQ:XNCRXencor Inc
19/09/202317:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
19/09/202317:01Business WireXencor Appoints Barbara J. Klencke, M.D., to Board of DirectorsNASDAQ:XNCRXencor Inc
03/08/202317:01Business WireXencor Reports Second Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
27/07/202309:01Business WireXencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023NASDAQ:XNCRXencor Inc
22/06/202318:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XNCRXencor Inc
16/06/202311:55Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XNCRXencor Inc
16/06/202311:42Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XNCRXencor Inc
15/06/202307:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XNCRXencor Inc
30/05/202319:01Business WireXencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 CongressNASDAQ:XNCRXencor Inc
08/05/202318:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XNCRXencor Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:XNCR

Seu Histórico Recente

HITB
STRAXETH
Stratis
USOTC
VAIAF
Vaisala OY (PK)
BIT
P1Q7G5
BNP Paribas Issuance
EU
0045N
Natixis Sa null
LSE
BLP
Blue Planet Investment
COIN
BTNTYUSD
Bitnity
BIT
F10250
Vontobel Financial Produ...
NASDAQ
LYFT
Lyft
NASDAQ
GPACW
Global Partner Acqusitio...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados